Cognitive Health & Longevity·9 min read·7 resources
Peptides for Cognition & Longevity
Semax, Selank, and Epithalon represent a distinct class of peptides studied for neuroprotection, cognitive enhancement, and biological aging. Here are 7 peer-reviewed and research-grade resources covering mechanisms from BDNF upregulation and GABAergic modulation to telomerase activation and circadian regulation.
Key Takeaways Across Sources
Semax upregulates BDNF and NGF, supports dopamine/serotonin signaling, and shows neuroprotective effects in stroke, Alzheimer's, and cognitive aging models.
Selank acts via GABAergic modulation to reduce anxiety and stress while supporting memory consolidation — often used alongside Semax for complementary cognitive effects.
Epithalon activates telomerase, supports telomere maintenance, regulates melatonin/circadian rhythms, and is studied for biological age reduction in gerontology contexts.
Intranasal delivery of Semax shows promising CNS bioavailability and cognitive improvements in animal models of Alzheimer's disease and ischemic stroke.
Most human evidence is limited to small trials and case series — particularly for Epithalon and Selank. Larger RCTs are needed before clinical conclusions can be drawn.
Curated Research Resources
7 peer-reviewed, clinical, and educational sources on Semax, Selank, and Epithalon for cognitive health and longevity.
2026 gerontology review covering Semax's neuroprotective and BDNF-related mechanisms for cognitive aging, Selank's anxiolytic and cognitive-support profile, and Epithalon's role in longevity research. One of the most current clinical overviews of all three peptides in an aging context.
Key points
Semax: neuroprotective mechanisms and BDNF upregulation in aging
Selank: anxiolytic effects and cognitive support in gerontology
Epithalon: longevity mechanisms and clinical gerontology context
Comparative overview of peptide therapy for cognitive aging
2
Peer-ReviewedSemaxPMC / PubMed Central2025
The Potential of Semax and Its Derivative for Cognitive Improvement in a Mouse Model of Alzheimer's Disease
2025 preclinical study demonstrating that intranasal Semax improves cognitive function in an Alzheimer's disease mouse model via neuroprotective pathways. Provides mechanistic evidence for Semax's potential in neurodegenerative disease prevention and cognitive preservation.
Key points
Intranasal Semax delivery and CNS bioavailability
Cognitive function improvement in AD mouse model
Neuroprotective pathway activation
Implications for Alzheimer's prevention and cognitive preservation
3
Peer-ReviewedSemaxPMC / PubMed Central2023
Neuroprotective Peptides and New Strategies for Ischemic Stroke Therapy
Review of neuroprotective peptide strategies for ischemic stroke, with Semax highlighted for significant protective effects in stroke models. Discusses implications for broader cognitive health, neuronal survival, and aging-related cerebrovascular risk.
Key points
Semax neuroprotection in ischemic stroke models
Neuronal survival and cerebrovascular protection mechanisms
Implications for cognitive health in aging populations
Peptide delivery strategies for CNS neuroprotection
4
Peer-ReviewedSemaxPMC / PubMed Central2022
Semax, a Synthetic Regulatory Peptide, Affects Copper-Induced Aggregation of Amyloid Beta
Investigates Semax's nootropic, neuroprotective, and neurotrophic properties with a focus on amyloid beta modulation. Demonstrates Semax's ability to affect copper-induced amyloid aggregation — a key pathological process in Alzheimer's disease — supporting its potential in prevention and treatment.
Key points
Semax modulation of copper-induced amyloid beta aggregation
Nootropic, neuroprotective, and neurotrophic properties
Alzheimer's disease prevention and treatment implications
Amyloid pathway as a target for cognitive peptide therapy
Comprehensive educational guide covering Semax (BDNF/NGF upregulation, clinical data summary), Selank (anxiolytic complement to Semax, GABAergic mechanism), and Epithalon (neuroprotective and longevity effects via telomerase activation and circadian regulation). Useful reference for understanding the full cognitive peptide stack.
Key points
Semax: BDNF/NGF upregulation and clinical evidence summary
Selank: GABAergic anxiolytic mechanism and cognitive complement
Epithalon: telomerase activation and circadian/neuroprotective effects
Practical overview of the cognitive peptide stack
6
Clinical ReviewEpithalonRestorative Medicine Journal2024
Improving Biological Age, Telomere Length, and Cognition with Peptide and Exosome Therapy
Clinical context article using Semax and Epithalon alongside exosome therapy for reduced biological age, telomere length support, BDNF and melatonin regulation, and cognitive benefits in aging patients. Provides a real-world clinical framing for longevity-focused peptide protocols.
Key points
Biological age reduction with Epithalon and Semax protocols
Telomere length support via telomerase activation
BDNF and melatonin regulation in aging
Clinical framing for longevity-focused peptide use
Mechanistic overview of Semax (BDNF upregulation, dopamine/serotonin modulation, memory and learning enhancement) and Selank (GABAergic anti-stress effects, cognitive support) for healthy aging and neuroprotection. Covers the rationale for combining both peptides in cognitive enhancement protocols.
Key points
Semax: BDNF, dopamine/serotonin, memory and learning mechanisms
Selank: GABAergic modulation and anti-stress cognitive support
Neuroprotective mechanisms for healthy aging
Rationale for Semax + Selank combination protocols
Research Context & Disclaimer
The resources on this page are provided for educational purposes only. Semax, Selank, and Epithalon are research peptides not approved by the FDA for human use. Most evidence comes from animal models and small human studies — larger randomized controlled trials are needed. Always consult a qualified healthcare provider before considering any peptide protocol. FLX Peptides does not sell, prescribe, or endorse the use of any compound.
